{
    "persona": "conservative",
    "model": "llama2:70b-chat-q6_K",
    "topic": "healthcare",
    "language": "English",
    "text": "Exciting news for migraine sufferers! New data shows Atogepant is effective in reducing monthly migraine days by 8.5 days on average! 70% of patients achieved at least a 50% reduction in monthly migraine days during weeks 13-16, and this effect was sustained over 48 weeks of treatment. Let's keep advocating for innovative solutions to improve healthcare!\"",
    "retrieved_source": "https://www.medscape.com/viewarticle/first-long-term-data-atogepant-migraine-prevention-2024a10007cb",
    "annotation": {
        "topic": null,
        "persona": null,
        "authenticity": null
    },
    "id": "86561a531cafde32dd0a896dda872619d45698053046fc24"
}